West Pharma gains on annual forecast raise

West Pharmaceutical Services

24/07/2025 14:17

Updates

** Shares of medical equipment maker West Pharmaceutical Services WST.N rise 23.2% to $280 premarket, set to open at its highest level since February, if gains hold

** Company expects annual adj. profit in the range of $6.65 to $6.85 per share, compared with previous range of $6.15 to $6.35 per share

** Forecasts annual sales in the range of $3.04 billion to $3.06 billion, compared with $2.95 billion to $2.98 billion projected earlier

** Company posts Q2 adj. profit of $1.84 per share, beating analysts' estimate of $1.51 per share - data compiled by LSEG

** Reports Q2 sales of $766.5 million, while analysts estimated $727.5 million

** Co's executive in post earnings call says it anticipates tariff impact of $15 mln to $20 mln in 2025, down from previous estimate of $20 mln to $25 mln

** Up to last close, shares down 30.6% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))